Log in

NASDAQ:XLRNAcceleron Pharma News Headlines

$96.04
-3.95 (-3.95 %)
(As of 07/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$95.88
Now: $96.04
$101.71
50-Day Range
$90.94
MA: $98.22
$104.80
52-Week Range
$37.60
Now: $96.04
$110.49
Volume529,530 shs
Average Volume683,228 shs
Market Capitalization$5.17 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.74

Headlines

Acceleron Pharma (NASDAQ XLRN) News Headlines

Source:
DateHeadline
Did Hedge Funds Make The Right Call On Acceleron Pharma Inc (XLRN) ?Did Hedge Funds Make The Right Call On Acceleron Pharma Inc (XLRN) ?
finance.yahoo.com - July 13 at 11:46 PM
Corp /De/ Celgene Sells 2,241 Shares of Acceleron Pharma Inc (NASDAQ:XLRN) StockCorp /De/ Celgene Sells 2,241 Shares of Acceleron Pharma Inc (NASDAQ:XLRN) Stock
www.marketbeat.com - July 13 at 9:27 PM
Acceleron Pharma Inc (NASDAQ:XLRN) to Post Q3 2020 Earnings of ($0.29) Per Share, Piper Sandler ForecastsAcceleron Pharma Inc (NASDAQ:XLRN) to Post Q3 2020 Earnings of ($0.29) Per Share, Piper Sandler Forecasts
www.americanbankingnews.com - July 9 at 7:36 AM
Acceleron Pharma Inc (NASDAQ:XLRN) Receives Consensus Rating of "Buy" from AnalystsAcceleron Pharma Inc (NASDAQ:XLRN) Receives Consensus Rating of "Buy" from Analysts
www.americanbankingnews.com - July 9 at 6:55 AM
Piper Sandler Weighs in on Acceleron Pharma Incs FY2023 Earnings (NASDAQ:XLRN)Piper Sandler Weighs in on Acceleron Pharma Inc's FY2023 Earnings (NASDAQ:XLRN)
www.americanbankingnews.com - July 8 at 7:12 AM
Acceleron Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional SharesAcceleron Announces Closing of Public Offering of Common Stock and Exercise of Underwriters’ Option to Purchase Additional Shares
finance.yahoo.com - July 7 at 5:56 PM
Acceleron Pharma (NASDAQ:XLRN) Given New $130.00 Price Target at Piper SandlerAcceleron Pharma (NASDAQ:XLRN) Given New $130.00 Price Target at Piper Sandler
www.marketbeat.com - July 7 at 7:28 AM
Acceleron Pharma (NASDAQ:XLRN) PT Lowered to $130.00Acceleron Pharma (NASDAQ:XLRN) PT Lowered to $130.00
www.americanbankingnews.com - July 7 at 7:27 AM
Acceleron Pharma Inc (NASDAQ:XLRN) Major Shareholder Purchases $9,999,990.00 in StockAcceleron Pharma Inc (NASDAQ:XLRN) Major Shareholder Purchases $9,999,990.00 in Stock
www.americanbankingnews.com - July 6 at 8:32 PM
Insider Selling: Acceleron Pharma Inc (NASDAQ:XLRN) CEO Sells 50,000 Shares of StockInsider Selling: Acceleron Pharma Inc (NASDAQ:XLRN) CEO Sells 50,000 Shares of Stock
www.marketbeat.com - July 6 at 8:32 PM
XLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the FirmXLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the Firm
finance.yahoo.com - July 6 at 5:57 PM
XLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the FirmXLRN Investor Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Acceleron Pharma Inc. and Encourages Investors to Contact the Firm
www.prnewswire.com - July 6 at 5:21 PM
Acceleron (XLRN) in Focus: Stock Moves 5.3% HigherAcceleron (XLRN) in Focus: Stock Moves 5.3% Higher
finance.yahoo.com - July 6 at 12:55 PM
Acceleron Pharma Inc (NASDAQ:XLRN) Expected to Post Quarterly Sales of $25.06 MillionAcceleron Pharma Inc (NASDAQ:XLRN) Expected to Post Quarterly Sales of $25.06 Million
www.americanbankingnews.com - July 5 at 2:38 AM
 Analysts Anticipate Acceleron Pharma Inc (NASDAQ:XLRN) to Announce -$0.66 Earnings Per Share Analysts Anticipate Acceleron Pharma Inc (NASDAQ:XLRN) to Announce -$0.66 Earnings Per Share
www.americanbankingnews.com - July 3 at 10:02 PM
The Petri Dish: Two new biotech IPOs and a $450M+ licensing dealThe Petri Dish: Two new biotech IPOs and a $450M+ licensing deal
www.bizjournals.com - July 2 at 9:32 AM
Head to Head Contrast: Acceleron Pharma (NASDAQ:XLRN) vs. Prevail Therapeutics (NASDAQ:PRVL)Head to Head Contrast: Acceleron Pharma (NASDAQ:XLRN) vs. Prevail Therapeutics (NASDAQ:PRVL)
www.americanbankingnews.com - July 2 at 8:32 AM
10 Stocks to Invest in the Health Care Revolution10 Stocks to Invest in the Health Care Revolution
finance.yahoo.com - July 1 at 1:03 PM
Acceleron prices stock offering at $92.50Acceleron prices stock offering at $92.50
seekingalpha.com - July 1 at 8:03 AM
Bristol Myers & Acceleron Obtain EC Approval for ReblozylBristol Myers & Acceleron Obtain EC Approval for Reblozyl
www.nasdaq.com - June 29 at 12:48 PM
Bristol Myers & Acceleron Obtain EC Approval for ReblozylBristol Myers & Acceleron Obtain EC Approval for Reblozyl
finance.yahoo.com - June 29 at 12:48 PM
Accelerons Sotatercept Trial, And Other News: The Good, Bad And Ugly Of BiopharmaAcceleron's Sotatercept Trial, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - June 28 at 4:43 PM
European Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta ThalassemiaEuropean Commission Approves Reblozyl (luspatercept) for the Treatment of Transfusion-Dependent Anemia in Adult Patients with Myelodysplastic Syndromes or Beta Thalassemia
finance.yahoo.com - June 26 at 11:40 AM
Acceleron Pharma (NASDAQ:XLRN) PT Raised to $132.00 at SVB LeerinkAcceleron Pharma (NASDAQ:XLRN) PT Raised to $132.00 at SVB Leerink
www.americanbankingnews.com - June 26 at 8:29 AM
Accelerons sotatercept successful in mid-stage PAH studyAcceleron's sotatercept successful in mid-stage PAH study
seekingalpha.com - June 25 at 12:51 PM
Acceleron Pharma (NASDAQ:XLRN) Price Target Increased to $140.00 by Analysts at CowenAcceleron Pharma (NASDAQ:XLRN) Price Target Increased to $140.00 by Analysts at Cowen
www.americanbankingnews.com - June 25 at 12:21 PM
Royal Bank of Canada Boosts Acceleron Pharma (NASDAQ:XLRN) Price Target to $99.00Royal Bank of Canada Boosts Acceleron Pharma (NASDAQ:XLRN) Price Target to $99.00
www.americanbankingnews.com - June 25 at 10:19 AM
Credit Suisse Group Raises Acceleron Pharma (NASDAQ:XLRN) Price Target to $134.00Credit Suisse Group Raises Acceleron Pharma (NASDAQ:XLRN) Price Target to $134.00
www.americanbankingnews.com - June 25 at 10:19 AM
Acceleron Pharma (NASDAQ:XLRN) Stock Rating Reaffirmed by OppenheimerAcceleron Pharma (NASDAQ:XLRN) Stock Rating Reaffirmed by Oppenheimer
www.americanbankingnews.com - June 25 at 6:21 AM
Accelerons sotatercept successful on mid-stage PAH studyAcceleron's sotatercept successful on mid-stage PAH study
seekingalpha.com - June 24 at 8:10 PM
Acceleron Presents Topline Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial HypertensionAcceleron Presents Topline Results of the PULSAR Phase 2 Trial of Sotatercept in Patients with Pulmonary Arterial Hypertension
finance.yahoo.com - June 24 at 8:10 PM
Acceleron Pharma stock jumps after positive heart-drug studyAcceleron Pharma stock jumps after positive heart-drug study
finance.yahoo.com - June 24 at 8:10 PM
Acceleron conference call Wednesday on mid-stage study of sotatercept in PAHAcceleron conference call Wednesday on mid-stage study of sotatercept in PAH
seekingalpha.com - June 22 at 1:04 PM
Acceleron to Host Conference Call and Webcast to Review Results of PULSAR Phase 2 Trial of Sotatercept Presented at American Thoracic Society 2020 Virtual ConferenceAcceleron to Host Conference Call and Webcast to Review Results of PULSAR Phase 2 Trial of Sotatercept Presented at American Thoracic Society 2020 Virtual Conference
finance.yahoo.com - June 22 at 8:03 AM
Stock Traders Buy High Volume of Call Options on Acceleron Pharma (NASDAQ:XLRN)Stock Traders Buy High Volume of Call Options on Acceleron Pharma (NASDAQ:XLRN)
www.americanbankingnews.com - June 19 at 3:26 PM
Acceleron (XLRN) Down 6.2% Since Last Earnings Report: Can It Rebound?Acceleron (XLRN) Down 6.2% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 10 at 1:49 PM
Acceleron Appoints Christopher Hite to its Board of DirectorsAcceleron Appoints Christopher Hite to its Board of Directors
finance.yahoo.com - June 4 at 6:55 PM
Hedge Funds Have Never Been This Bullish On Acceleron Pharma Inc (XLRN)Hedge Funds Have Never Been This Bullish On Acceleron Pharma Inc (XLRN)
finance.yahoo.com - June 1 at 5:33 PM
Acceleron Announces Presentations on REBLOZYL® (luspatercept-aamt) at the 2020 American Society of Clinical Oncology and European Hematology Association Virtual Annual MeetingsAcceleron Announces Presentations on REBLOZYL® (luspatercept-aamt) at the 2020 American Society of Clinical Oncology and European Hematology Association Virtual Annual Meetings
finance.yahoo.com - May 20 at 8:10 AM
Acceleron Announces Oral Presentation of PULSAR Phase 2 Trial Results in Virtual American Thoracic Society 2020 Conference Session on June 24, 2020Acceleron Announces Oral Presentation of PULSAR Phase 2 Trial Results in Virtual American Thoracic Society 2020 Conference Session on June 24, 2020
finance.yahoo.com - May 19 at 1:44 PM
Acceleron Announces Publication in Science Translational Medicine Describing the Underlying Biology Behind Sotatercept’s Potential as a Novel Therapy in Pulmonary Arterial HypertensionAcceleron Announces Publication in Science Translational Medicine Describing the Underlying Biology Behind Sotatercept’s Potential as a Novel Therapy in Pulmonary Arterial Hypertension
finance.yahoo.com - May 13 at 6:35 PM
Acceleron Pharma Inc (XLRN) Q1 2020 Earnings Call TranscriptAcceleron Pharma Inc (XLRN) Q1 2020 Earnings Call Transcript
www.nasdaq.com - May 12 at 9:20 PM
Acceleron (XLRN) Q1 Loss Wider Than Expected, Revenues MissAcceleron (XLRN) Q1 Loss Wider Than Expected, Revenues Miss
finance.yahoo.com - May 12 at 4:17 PM
Edited Transcript of XLRN earnings conference call or presentation 11-May-20 9:00pm GMTEdited Transcript of XLRN earnings conference call or presentation 11-May-20 9:00pm GMT
finance.yahoo.com - May 12 at 4:17 PM
Acceleron Pharma (XLRN) Reports Q1 Loss, Lags Revenue EstimatesAcceleron Pharma (XLRN) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 11 at 10:12 PM
Acceleron Pharma EPS misses by $0.09, misses on revenueAcceleron Pharma EPS misses by $0.09, misses on revenue
seekingalpha.com - May 11 at 5:11 PM
Acceleron Reports First Quarter 2020 Operating and Financial ResultsAcceleron Reports First Quarter 2020 Operating and Financial Results
finance.yahoo.com - May 11 at 5:11 PM
Acceleron Pharma Q1 2020 Earnings PreviewAcceleron Pharma Q1 2020 Earnings Preview
seekingalpha.com - May 10 at 9:52 PM
Acceleron to Webcast First Quarter 2020 Operating and Financial Results on May 11, 2020Acceleron to Webcast First Quarter 2020 Operating and Financial Results on May 11, 2020
finance.yahoo.com - May 5 at 9:47 AM
EMA grants PRIME designation to Accelerons sotaterceptEMA grants PRIME designation to Acceleron's sotatercept
seekingalpha.com - May 4 at 1:10 PM
This page was last updated on 7/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.